ESR1 and breast carcinoma: Additionally, calcineurin—a Ca2+ dependent phosphatase highly expressed in ERα−positive breast cancer with poor endocrine therapy response—stabilizes ERα by dephosphorylating Ser294, thereby preventing its degradation (175).